Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2012 Nov 7;16(6):454; author reply 454.
doi: 10.1186/cc11673.

CRYSTMAS study adds to concerns about renal safety and increased mortality in sepsis patients

Comment

CRYSTMAS study adds to concerns about renal safety and increased mortality in sepsis patients

Christiane S Hartog et al. Crit Care. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Kaplan-Meier curves for time to renal replacement therapy. Figure taken from the Voluven package insert [3].
Figure 2
Figure 2
28-day and 90-day mortality rates associated with 10% HES 200/0.5 and 6% HES 130/0.4 versus crystalloids in two multicenter randomised controlled studies of patients with severe sepsis.

Comment on

References

    1. Guidet B, Martinet O, Boulain T, Philippart F, Poussel JF, Maizel J, Forceville X, Feissel M, Hasselmann M, Heininger A, Van Aken H. Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: The CRYSTMAS study. Crit Care. 2012;16:R94. doi: 10.1186/cc11358. - DOI - PMC - PubMed
    1. Perner A, Haase N, Wetterslev J, Aneman A, Tenhunen J, Guttormsen AB, Klemenzson G, Pott F, Bødker KD, Bådstøløkken PM, Bendtsen A, Søe-Jensen P, Tousi H, Bestle M, Pawlowicz M, Winding R, Bülow HH, Kancir C, Steensen M, Nielsen J, Fogh B, Madsen KR, Larsen NH, Carlsson M, Wiis J, Petersen JA, Iversen S, Schøidt O, Leivdal S, Berezowicz P. et al.Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S - Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for a double-blinded, randomised clinical trial. Trials. 2011;16:24. doi: 10.1186/1745-6215-12-24. - DOI - PMC - PubMed
    1. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K. German Competence Network Sepsis (SepNet) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;16:125–139. doi: 10.1056/NEJMoa070716. - DOI - PubMed
    1. Package insert Voluven. http://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBloodProducts/A...
    1. McGauran N, Wieseler B, Kreis J, Schuler YB, Kolsch H, Kaiser T. Reporting bias in medical research - a narrative review. Trials. 2010;16:37. doi: 10.1186/1745-6215-11-37. - DOI - PMC - PubMed

Substances